Agha AM, Parwani P, Guha A, et al. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart 2018;5:e000881. doi:10.1136/openhrt-2018-000881This article has been corrected since it first published. The authors want to inform the readers on the following two changes.The second paragraph under the sub-heading ‘Late gadolinium enhancement’ of ‘Cardiovascular magnetic resonance’, should read as:Although a very useful technique, a challenge with LGE is to choose an appropriate inversion time (TI) value. This TI value is a baseline where the myocardium is black or ‘nulled’. Incorrect determination of this null point may mask evidence of amyloidosis.27 A technique called ‘phase-sensitive inversion recovery’ allows for the automated determination of an ideal TI time and may prevent user error from incorrectly masking amyloidosis on CMR27 (see figure 4).The third paragraph under the sub-heading ‘T1 mapping’ of ‘Cardiovascular magnetic resonance’, should read as:A pre-contrast T1 time of greater than 1044 ms has been associated with a poor prognosis in AL amyloidosis.31 A similar cut-off of greater than 1077 ms has been associated with worse prognosis for ATTRamyloidosis, but not particularly prognostic when separated by familial and wild-type ATTR.32